USD 3.94
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1.34 Million USD | -10.18% |
2022 | 1.49 Million USD | -15.52% |
2021 | 1.77 Million USD | -2.65% |
2020 | 1.82 Million USD | 72.14% |
2019 | 1.05 Million USD | 50.16% |
2018 | 704.56 Thousand USD | 74.46% |
2017 | 403.86 Thousand USD | 32.57% |
2016 | 304.63 Thousand USD | 0.0% |
2011 | 480 Thousand USD | 17.36% |
2010 | 409 Thousand USD | -9.31% |
2009 | 451 Thousand USD | -24.46% |
2008 | 597 Thousand USD | -3.86% |
2007 | 621 Thousand USD | 65.16% |
2006 | 376 Thousand USD | -19.31% |
2005 | 466 Thousand USD | 57.97% |
2004 | 295 Thousand USD | 8.86% |
2003 | 271 Thousand USD | 8.4% |
2002 | 250 Thousand USD | -24.24% |
2001 | 330 Thousand USD | -62.75% |
2000 | 886 Thousand USD | -1.56% |
1999 | 900 Thousand USD | 28.57% |
1998 | 700 Thousand USD | -22.22% |
1997 | 900 Thousand USD | -10.0% |
1996 | 1 Million USD | -81.13% |
1995 | 5.3 Million USD | 6.0% |
1994 | 5 Million USD | 284.62% |
1993 | 1.3 Million USD | 30.0% |
1992 | 1 Million USD | -23.08% |
1991 | 1.3 Million USD | 18.18% |
1990 | 1.1 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 1.13 Million USD | -15.94% |
2024 Q3 | 1.31 Million USD | 21.89% |
2024 Q2 | 1.08 Million USD | -4.41% |
2023 Q3 | 1.14 Million USD | -3.53% |
2023 Q2 | 1.18 Million USD | -1.37% |
2023 Q1 | 1.2 Million USD | -19.65% |
2023 FY | 1.34 Million USD | -10.18% |
2023 Q4 | 1.34 Million USD | 17.47% |
2022 Q2 | 1.74 Million USD | -9.19% |
2022 Q4 | 1.49 Million USD | -9.69% |
2022 Q1 | 1.92 Million USD | 8.66% |
2022 FY | 1.49 Million USD | -15.52% |
2022 Q3 | 1.65 Million USD | -5.19% |
2021 Q2 | 1.75 Million USD | 0.0% |
2021 Q4 | 1.77 Million USD | -4.37% |
2021 Q3 | 1.85 Million USD | 5.36% |
2021 FY | 1.77 Million USD | -2.65% |
2020 FY | 1.82 Million USD | 72.14% |
2019 FY | 1.05 Million USD | 50.16% |
2018 FY | 704.56 Thousand USD | 74.46% |
2017 FY | 403.86 Thousand USD | 32.57% |
2016 FY | 304.63 Thousand USD | 0.0% |
2011 Q3 | 504 Thousand USD | -3.45% |
2011 Q4 | 480 Thousand USD | -4.76% |
2011 FY | 480 Thousand USD | 17.36% |
2011 Q1 | 440 Thousand USD | 7.58% |
2011 Q2 | 522 Thousand USD | 18.64% |
2010 Q3 | 428 Thousand USD | -6.55% |
2010 Q1 | 479 Thousand USD | 6.21% |
2010 Q2 | 458 Thousand USD | -4.38% |
2010 Q4 | 409 Thousand USD | -4.44% |
2010 FY | 409 Thousand USD | -9.31% |
2009 Q3 | 443 Thousand USD | -17.35% |
2009 FY | 451 Thousand USD | -24.46% |
2009 Q1 | 533 Thousand USD | -10.72% |
2009 Q4 | 451 Thousand USD | 1.81% |
2009 Q2 | 536 Thousand USD | 0.56% |
2008 Q3 | 604 Thousand USD | -12.72% |
2008 Q1 | 681 Thousand USD | 9.66% |
2008 Q2 | 692 Thousand USD | 1.62% |
2008 Q4 | 597 Thousand USD | -1.16% |
2008 FY | 597 Thousand USD | -3.86% |
2007 FY | 621 Thousand USD | 65.16% |
2007 Q4 | 621 Thousand USD | 23.71% |
2007 Q1 | 438 Thousand USD | 16.49% |
2007 Q3 | 502 Thousand USD | 10.82% |
2007 Q2 | 453 Thousand USD | 3.42% |
2006 Q1 | 487 Thousand USD | 4.51% |
2006 Q4 | 376 Thousand USD | -0.53% |
2006 Q2 | 432 Thousand USD | -11.29% |
2006 Q3 | 378 Thousand USD | -12.5% |
2006 FY | 376 Thousand USD | -19.31% |
2005 Q3 | 416 Thousand USD | -4.15% |
2005 FY | 466 Thousand USD | 57.97% |
2005 Q4 | 466 Thousand USD | 12.02% |
2005 Q2 | 434 Thousand USD | 26.9% |
2005 Q1 | 342 Thousand USD | 15.93% |
2004 Q4 | 295 Thousand USD | 2.43% |
2004 Q3 | 288 Thousand USD | -4.0% |
2004 FY | 295 Thousand USD | 8.86% |
2004 Q1 | 223 Thousand USD | -17.71% |
2004 Q2 | 300 Thousand USD | 34.53% |
2003 Q1 | 302 Thousand USD | 20.8% |
2003 Q2 | 250 Thousand USD | -17.22% |
2003 Q4 | 271 Thousand USD | 15.81% |
2003 FY | 271 Thousand USD | 8.4% |
2003 Q3 | 234 Thousand USD | -6.4% |
2002 Q2 | 263 Thousand USD | -16.24% |
2002 Q4 | 250 Thousand USD | -38.12% |
2002 FY | 250 Thousand USD | -24.24% |
2002 Q1 | 314 Thousand USD | -4.85% |
2002 Q3 | 404 Thousand USD | 53.61% |
2001 Q4 | 330 Thousand USD | -10.33% |
2001 Q2 | 432 Thousand USD | -29.18% |
2001 Q3 | 368 Thousand USD | -14.81% |
2001 Q1 | 610 Thousand USD | -31.15% |
2001 FY | 330 Thousand USD | -62.75% |
2000 Q3 | 864 Thousand USD | 6.27% |
2000 FY | 886 Thousand USD | -1.56% |
2000 Q4 | 886 Thousand USD | 2.55% |
2000 Q2 | 813 Thousand USD | 16.14% |
2000 Q1 | 700 Thousand USD | -22.22% |
1999 Q3 | 700 Thousand USD | -12.5% |
1999 Q4 | 900 Thousand USD | 28.57% |
1999 FY | 900 Thousand USD | 28.57% |
1999 Q2 | 800 Thousand USD | 33.33% |
1999 Q1 | 600 Thousand USD | -14.29% |
1998 Q4 | 700 Thousand USD | -12.5% |
1998 FY | 700 Thousand USD | -22.22% |
1998 Q1 | 800 Thousand USD | -11.11% |
1998 Q2 | 800 Thousand USD | 0.0% |
1998 Q3 | 800 Thousand USD | 0.0% |
1997 Q1 | 1 Million USD | 0.0% |
1997 Q3 | 900 Thousand USD | -18.18% |
1997 Q2 | 1.1 Million USD | 10.0% |
1997 Q4 | 900 Thousand USD | 0.0% |
1997 FY | 900 Thousand USD | -10.0% |
1996 Q1 | 5.4 Million USD | 1.89% |
1996 Q4 | 1 Million USD | -60.0% |
1996 Q3 | 2.5 Million USD | -51.92% |
1996 Q2 | 5.2 Million USD | -3.7% |
1996 FY | 1 Million USD | -81.13% |
1995 Q2 | 5.2 Million USD | 0.0% |
1995 FY | 5.3 Million USD | 6.0% |
1995 Q4 | 5.3 Million USD | 6.0% |
1995 Q3 | 5 Million USD | -3.85% |
1994 Q3 | 1.2 Million USD | 9.09% |
1994 Q2 | 1.1 Million USD | -31.25% |
1994 Q1 | 1.6 Million USD | 23.08% |
1994 FY | 5 Million USD | 284.62% |
1994 Q4 | 5 Million USD | 316.67% |
1993 Q4 | 1.3 Million USD | 30.0% |
1993 Q3 | 1 Million USD | 0.0% |
1993 FY | 1.3 Million USD | 30.0% |
1992 Q2 | 1.1 Million USD | 0.0% |
1992 Q4 | 1 Million USD | 0.0% |
1992 FY | 1 Million USD | -23.08% |
1991 Q1 | 800 Thousand USD | -27.27% |
1991 Q4 | 1.3 Million USD | 0.0% |
1991 FY | 1.3 Million USD | 18.18% |
1990 FY | 1.1 Million USD | 0.0% |
1990 Q4 | 1.1 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Achiko AG | 6.49 Million USD | 79.301% |
Accelera Innovations, Inc | - USD | -Infinity% |
Aspyra Inc. | 8.37 Million USD | 83.932% |
Cannabis Sativa, Inc. | 1.26 Million USD | -6.5% |
CompuGroup Medical SE & Co. KGaA | 1.45 Billion USD | 99.908% |
Cogstate Limited | 16.91 Million USD | 92.047% |
CareView Communications, Inc. | 40.52 Million USD | 96.68% |
Craneware plc | 215.06 Million USD | 99.374% |
Caduceus Software Systems Corp. | 5.57 Million USD | 75.869% |
Certive Solutions Inc. | 10.95 Million USD | 87.722% |
Drug Free Solution, Inc. | 333.29 Thousand USD | -303.623% |
DATATRAK International, Inc. | 6.18 Million USD | 78.233% |
Strainsforpains, Inc. | 2.61 Million USD | 48.472% |
Healixa Inc. | 10.57 Million USD | 87.278% |
Easy Technologies Inc. | - USD | -Infinity% |
eWellness Healthcare Corporation | - USD | -Infinity% |
Founders Bay Holdings | 138.29 Thousand USD | -872.79% |
Health Discovery Corporation | - USD | -Infinity% |
Healthcare Integrated Technologies, Inc. | 1.02 Million USD | -31.564% |
H-Source Holdings Ltd. | - USD | -Infinity% |
InterCare DX, Inc. | 5068.58 USD | -26441.378% |
iCoreConnect Inc. | 11.24 Million USD | 88.034% |
IQ-AI Limited | 796.65 Thousand USD | -68.864% |
Cannabiz Mobile, Inc. | 559.05 Thousand USD | -140.634% |
Mednow Inc. | 9.46 Million USD | 85.793% |
Galileo Life Sciences, Inc. | 725.46 Thousand USD | -85.435% |
MediXall Group, Inc. | 4.53 Million USD | 70.312% |
Mitesco, Inc. | 14.13 Million USD | 90.482% |
MobileSmith, Inc. | 6.15 Million USD | 78.143% |
NantHealth, Inc. | 384.94 Million USD | 99.651% |
Net Medical Xpress Solutions, Inc. | 1.07 Million USD | -24.793% |
OneLife Technologies Corp. | - USD | -Infinity% |
ORHub, Inc. | 11.33 Million USD | 88.128% |
Patient Access Solutions, Inc. | 2.44 Million USD | 44.955% |
Pharma-Bio Serv, Inc. | 3.77 Million USD | 64.366% |
PPJ Healthcare Enterprises, Inc. | 7.03 Million USD | 80.889% |
Medical Cannabis Payment Solutions, Inc. | 2.36 Million USD | 43.137% |
Renalytix Plc | 15.82 Million USD | 91.5% |
Revium Recovery Inc. | 144 Thousand USD | -834.216% |
RYAH Group, Inc. | - USD | -Infinity% |
Carepay Inc. | 3.06 Million USD | 56.076% |
Vaso Corporation | 48.91 Million USD | 97.25% |
Vynleads, Inc. | 805.33 Thousand USD | -67.046% |